Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.824 USD | +0.37% | -2.09% | -13.34% |
Financials (USD)
Sales 2024 * | 2.33M | Sales 2025 * | 3.33M | Capitalization | 59.77M |
---|---|---|---|---|---|
Net income 2024 * | -102M | Net income 2025 * | -111M | EV / Sales 2024 * | 25.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 17.9 x |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-0.66
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.19% |
Latest transcript on Kezar Life Sciences, Inc.
1 day | -2.26% | ||
1 week | -2.09% | ||
Current month | -0.42% | ||
1 month | +1.73% | ||
3 months | -13.33% | ||
6 months | -1.97% | ||
Current year | -13.34% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 16-10-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.821 | -2.26% | 620 204 |
24-05-07 | 0.84 | +3.11% | 453,290 |
24-05-06 | 0.8147 | -4.98% | 497,544 |
24-05-03 | 0.8574 | +0.32% | 193,867 |
24-05-02 | 0.8547 | +1.93% | 659,673 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.34% | 59.77M | |
+2.93% | 108B | |
-2.50% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- KZR Stock